1994
DOI: 10.1007/978-3-642-85036-3_29
|View full text |Cite
|
Sign up to set email alerts
|

Modulating Effects of Pentoxifylline on Cytokine Release Syndromes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1996
1996
1996
1996

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 26 publications
0
1
0
Order By: Relevance
“…Another promising approach to attenuate an excessive systemic inflammatory response consists in the use of xanthine derivatives such as pentoxifylline (POF). It is known that POF selectively inhibits the formation of TNF␣, likely by causing accumulation of intracellular cAMP [20]. Furthermore, POF is able to counteract neutrophil adherence to the endothelium and protect from increased pulmonary vascular permeability in the lung.…”
Section: Antiinflammatory Therapeutic Approachesmentioning
confidence: 99%
“…Another promising approach to attenuate an excessive systemic inflammatory response consists in the use of xanthine derivatives such as pentoxifylline (POF). It is known that POF selectively inhibits the formation of TNF␣, likely by causing accumulation of intracellular cAMP [20]. Furthermore, POF is able to counteract neutrophil adherence to the endothelium and protect from increased pulmonary vascular permeability in the lung.…”
Section: Antiinflammatory Therapeutic Approachesmentioning
confidence: 99%